Pharmaceutical tariffs are coming, part of President Trump’s stated goal of bringing drug manufacturing back to the U.S. Untangling the sprawling, global supply chain will be complicated and expensive, and could inadvertently compete with other administration goals regarding drug pricing and availability.
The post The Myth of All-American Drugs and What Trump’s Tariffs Miss About Pharma Supply Chains appeared first on MedCity News.
